Holen Sie sich die Stockscreener-App
117.13
2.64%
3.01
Handel nachbörslich:
122.66
5.53
+4.72%
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Repligen’s 39% decline validates InvestingPro’s January 2024 bearish call By Investing.com - Investing.com
Repligen (RGEN) Receives Overweight Rating with $160 Price Targe - GuruFocus
Here's Why Repligen (RGEN) is a Strong Growth Stock - Yahoo Finance
Repligen FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
What analysts say about Repligen Corporation stockExplosive portfolio gains - printweek.in
Envestnet Asset Management Inc. Reduces Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp to Release Q2 2025 Financial Results and Host Conference Call on July 29, 2025. - AInvest
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
M&T Bank Corp Reduces Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen to Report Second Quarter 2025 Financial Results - The Globe and Mail
Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative
How KEY.PRK stock performs during market volatilityFree Consultation - Newser
Why DOCU stock attracts strong analyst attentionHigh Potential Shares - Newser
How Life360 Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
Protein Purification and Isolation Market Size to Surpass USD 33.02 Billion by 2034 - BioSpace
Parnassus Mid Cap Growth Fund Q2 2025 Commentary - Seeking Alpha
Parnassus Mid Cap Fund Q2 2025 Commentary - Seeking Alpha
Why Repligen Corporation stock attracts strong analyst attentionInstant Stock Updates - Newser
What makes ScanSource Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes HUTCHMED (China) Limited Depositary Receipt stock price move sharplyFree Join Group - Newser
How Repligen Corporation stock performs during market volatility200 Percent Profit Outlook - Newser
Why Sphere 3D Corp. stock attracts strong analyst attentionFree Stock Trading Community - Newser
Why ROAD stock attracts strong analyst attentionTop Analyst Picks - Newser
Evercore ISI Cuts Repligen (NASDAQ:RGEN) Price Target to $130.00 - Defense World
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value - Yahoo Finance
GAMMA Investing LLC Boosts Holdings in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Purchased by KBC Group NV - Defense World
Fluor Corporation (NYSE:FLR) Shares Sold by Amalgamated Bank - Defense World
Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold - Defense World
Improving Process Reliability in mAb Manufacturing - Genetic Engineering and Biotechnology News
Barclays Initiates Coverage on Repligen (RGEN) with Positive Out - GuruFocus
Barclays initiates Repligen stock with overweight rating on bioprocessing strength - Investing.com
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025 - Yahoo Finance
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada
Repligen at William Blair Conference: Innovation Drives Growth - Investing.com
Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance
Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK
Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance
Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia
Insider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN) - GuruFocus
Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Mercer Global Advisors Inc. ADV Sells 1,039 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
2.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):